CRLBF
Price
$1.64
Change
-$0.00 (-0.00%)
Updated
Oct 4 closing price
26 days until earnings call
TCNNF
Price
$12.15
Change
-$0.00 (-0.00%)
Updated
Oct 4 closing price
21 days until earnings call
Ad is loading...

CRLBF vs TCNNF

Header iconCRLBF vs TCNNF Comparison
Open Charts CRLBF vs TCNNFBanner chart's image
Cresco Labs
Price$1.64
Change-$0.00 (-0.00%)
Volume$482.75K
CapitalizationN/A
Trulieve Cannabis
Price$12.15
Change-$0.00 (-0.00%)
Volume$203.52K
CapitalizationN/A
View a ticker or compare two or three
CRLBF vs TCNNF Comparison Chart
Loading...
CRLBF
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TCNNF
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CRLBF vs. TCNNF commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRLBF is a StrongSell and TCNNF is a StrongBuy.

COMPARISON
Comparison
Oct 18, 2024
Stock price -- (CRLBF: $1.60 vs. TCNNF: $12.35)
Brand notoriety: CRLBF and TCNNF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CRLBF: 78% vs. TCNNF: 75%
Market capitalization -- CRLBF: $501.04M vs. TCNNF: $788.54M
CRLBF [@Pharmaceuticals: Other] is valued at $501.04M. TCNNF’s [@Pharmaceuticals: Other] market capitalization is $788.54M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRLBF’s FA Score shows that 0 FA rating(s) are green whileTCNNF’s FA Score has 1 green FA rating(s).

  • CRLBF’s FA Score: 0 green, 5 red.
  • TCNNF’s FA Score: 1 green, 4 red.
According to our system of comparison, TCNNF is a better buy in the long-term than CRLBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRLBF’s TA Score shows that 3 TA indicator(s) are bullish while TCNNF’s TA Score has 4 bullish TA indicator(s).

  • CRLBF’s TA Score: 3 bullish, 5 bearish.
  • TCNNF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TCNNF is a better buy in the short-term than CRLBF.

Price Growth

CRLBF (@Pharmaceuticals: Other) experienced а -1.93% price change this week, while TCNNF (@Pharmaceuticals: Other) price change was +5.56% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +8.21%. For the same industry, the average monthly price growth was +10.22%, and the average quarterly price growth was -2.43%.

Reported Earning Dates

CRLBF is expected to report earnings on Mar 13, 2025.

TCNNF is expected to report earnings on Mar 26, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+8.21% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TCNNF($789M) has a higher market cap than CRLBF($501M). TCNNF YTD gains are higher at: 130.902 vs. CRLBF (17.901). TCNNF has higher annual earnings (EBITDA): 187M vs. CRLBF (-16.73M). TCNNF has more cash in the bank: 188M vs. CRLBF (88.8M). CRLBF has less debt than TCNNF: CRLBF (678M) vs TCNNF (1.02B). TCNNF has higher revenues than CRLBF: TCNNF (1.21B) vs CRLBF (822M).
CRLBFTCNNFCRLBF / TCNNF
Capitalization501M789M63%
EBITDA-16.73M187M-9%
Gain YTD17.901130.90214%
P/E RatioN/A120.48-
Revenue822M1.21B68%
Total Cash88.8M188M47%
Total Debt678M1.02B66%
FUNDAMENTALS RATINGS
CRLBF vs TCNNF: Fundamental Ratings
CRLBF
TCNNF
OUTLOOK RATING
1..100
647
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
87
Overvalued
PROFIT vs RISK RATING
1..100
10089
SMR RATING
1..100
9693
PRICE GROWTH RATING
1..100
7839
P/E GROWTH RATING
1..100
10028
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRLBF's Valuation (80) in the null industry is in the same range as TCNNF (87). This means that CRLBF’s stock grew similarly to TCNNF’s over the last 12 months.

TCNNF's Profit vs Risk Rating (89) in the null industry is in the same range as CRLBF (100). This means that TCNNF’s stock grew similarly to CRLBF’s over the last 12 months.

TCNNF's SMR Rating (93) in the null industry is in the same range as CRLBF (96). This means that TCNNF’s stock grew similarly to CRLBF’s over the last 12 months.

TCNNF's Price Growth Rating (39) in the null industry is somewhat better than the same rating for CRLBF (78). This means that TCNNF’s stock grew somewhat faster than CRLBF’s over the last 12 months.

TCNNF's P/E Growth Rating (28) in the null industry is significantly better than the same rating for CRLBF (100). This means that TCNNF’s stock grew significantly faster than CRLBF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRLBFTCNNF
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 24 days ago
84%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 16 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
CRLBF
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TCNNF
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL232.150.37
+0.16%
Apple
SPY582.350.05
+0.01%
SPDR® S&P 500® ETF Trust
TSLA220.89-0.44
-0.20%
Tesla
BTC.X67399.836000-212.882810
-0.31%
Bitcoin cryptocurrency
GME21.41-0.25
-1.15%
GameStop Corp

TCNNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCNNF has been closely correlated with GTBIF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if TCNNF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCNNF
1D Price
Change %
TCNNF100%
+0.84%
GTBIF - TCNNF
82%
Closely correlated
+1.02%
CURLF - TCNNF
78%
Closely correlated
-1.00%
VRNOF - TCNNF
77%
Closely correlated
+2.17%
TSNDF - TCNNF
76%
Closely correlated
+2.59%
CRLBF - TCNNF
75%
Closely correlated
-0.32%
More